Alvotech (ALVO) Q4 2025 Earnings Call Transcript

Operator

Good day, and thank you for standing by. Welcome to the Alvotech Q4 2025 and Full Year 2025 Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded.

I would now like to hand the conference over to your speaker today, Mikaela Vilchez. Please go ahead.

Mikaela Vilchez

Thank you, and welcome to our listeners. Yesterday evening, the company issued a press release announcing our financial results for the full year and fourth quarter of 2025. Material accompanying today’s earnings call was also published on our investor portal, investors.alvotech.com in the earnings calendar section.

Our press release, presentation and statements that we make on the call today may include forward-looking statements. These statements do not ensure future performance and are subject to risks and uncertainties that are outlined in the company filings with the Securities and Exchange Commission. Any risks and uncertainties could cause actual results to differ materially from forward-looking statements that are made.

Presenting on today’s call are Robert Wessman, Founder and Executive Chairman; Lisa Graver, Chief Executive Officer Designate; Joseph McClellan, Chief Operating Officer; Linda Jonsdottir, Chief Financial Officer. Also with us on the call is Balaji Prasad, Chief Strategy Officer.

Robert will begin today’s presentation with a summary of business highlights. Lisa will then present a commercial update. Joseph will discuss the status of our pending biologics license applications with the FDA and our R&D pipeline. Linda